Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 2,339

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Worldwide access to treatment for end-stage kidney disease: a systematic review

Liyanage, Thaminda, Ninomiya, Toshiharu, Jha, Vivekanand, Neal, Bruce, Patrice, Halle Marie, Okpechi, Ikechi, Zhao, Ming-hui, Lv, Jicheng, Garg, Amit X, Knight, John, Rodgers, Anthony, Gallagher, Martin, Kotwal, Sradha, Cass, Alan, Perkovic, Vlado·2015·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(14)61601-9

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 19

  1. White, 2008, How can we achieve global equity in provision of renal replacement therapy?, Bull World Health Organ, 86, 229, 10.2471/BLT.07.041715 · DOI · Paper page
  2. Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 · DOI · Paper page
  3. Kearney, 2005, Global burden of hypertension: analysis of worldwide data, Lancet, 365, 217, 10.1016/S0140-6736(05)17741-1 · DOI · Paper page
  4. Barros, 2003, Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio, BMC Med Res Methodol, 3, 21, 10.1186/1471-2288-3-21 · DOI · Paper page
  5. Hemmelgarn, 2012, Rates of treated and untreated kidney failure in older vs younger adults, JAMA, 307, 2507, 10.1001/jama.2012.6455 · DOI
  6. Sparke, 2013, Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation, Am J Kidney Dis, 61, 413, 10.1053/j.ajkd.2012.10.012 · DOI
  7. Steyerberg, 2004, Validation and updating of predictive logistic regression models: a study on sample size and shrinkage, Stat Med, 23, 2567, 10.1002/sim.1844 · DOI · Paper page
  8. Lysaght, 2002, Maintenance dialysis population dynamics: current trends and long-term implications, J Am Soc Nephrol, 13, S37, 10.1681/ASN.V13suppl_1s37 · DOI · Paper page
  9. Grassmann, 2005, ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends, Nephrol Dial Transplant, 20, 2587, 10.1093/ndt/gfi159 · DOI · Paper page
  10. Anand, 2013, The gap between estimated incidence of end-stage renal disease and use of therapy, PloS One, 8, e72860, 10.1371/journal.pone.0072860 · DOI
  11. Jha, 2004, End-stage renal care in developing countries: the India experience, Ren Fail, 26, 201, 10.1081/JDI-120039516 · DOI
  12. Ehrich, 2005, Demography of paediatric renal care in Europe: organization and delivery, Nephrol Dial Transplant, 20, 297, 10.1093/ndt/gfh299 · doi:10.1093/ndt/gfh299
  13. Lv, 2013, Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis, Can Med Assoc J, 185, 949, 10.1503/cmaj.121468 · DOI · Paper page
  14. Bedford, 2012, Acute kidney injury and CKD: chicken or egg?, Am J Kidney Dis, 59, 485, 10.1053/j.ajkd.2011.09.010 · DOI
  15. Joshi, 2008, Global inequalities in access to cardiovascular health care: our greatest challenge, J Am Coll Cardiol, 52, 1817, 10.1016/j.jacc.2008.08.049 · DOI · Paper page
  16. Mazzuchi, 2006, Risk factors and prevention of end stage renal disease in Uruguay, Ren Fail, 28, 617, 10.1080/08860220600925677 · DOI
  17. Wei, 2010, Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs, Nephrology, 15, 108, 10.1111/j.1440-1797.2009.01154.x · DOI
  18. Lin, 2013, Progression of stages 3b–5 chronic kidney disease—preliminary results of Taiwan national pre-ESRD disease management program in Southern Taiwan, J Formos Med Assoc, 112, 773, 10.1016/j.jfma.2013.10.021 · DOI
  19. Rayner, 2014, Does community-wide chronic kidney disease management improve patient outcomes?, Nephrol Dial Transplant, 29, 644, 10.1093/ndt/gft486 · doi:10.1093/ndt/gft486

Cited by

See all 2,339

Metadata

Authors
Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., Zhao, M.-H., Lv, J., Garg, A. X., Knight, J., Rodgers, A., Gallagher, M., Kotwal, S., Cass, A., & Perkovic, V.
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-05
Volume
385
Issue
9981
Pages
1975-1982
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2133169646
Cited by
2,339
References
4
FWCI
21.22
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Baxter International
  • Novartis
  • National Health and Medical Research Council (APP100311, 105255)
  • Amgen
  • Merck
  • Australian Government
  • Australian Research Council (DP100100295)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Worldwide access to treatment for end-stage kidney disease: a systematic review. https://app.cochat.ai/papers/10.1016/s0140-6736(14)61601-9
The paper
Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., Zhao, M.-H., Lv, J., Garg, A. X., Knight, J., Rodgers, A., Gallagher, M., Kotwal, S., Cass, A., & Perkovic, V. (2015). Worldwide access to treatment for end-stage kidney disease: a systematic review. The Lancet. https://doi.org/10.1016/s0140-6736(14)61601-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.